Characterisation of the novel SCN5A-P1891A variant, implicated in left ventricular noncompaction cardiomyopathy in a Finnish family, using human induced pluripotent stem cell-derived cardiomyocytes.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel insights into arrhythmias Cardiomyopathies ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by